News Amedisys, Inc.

Equities

AMED

US0234361089

Delayed Nasdaq Other stock markets 03:53:19 2024-04-24 pm EDT			5-day change	1st Jan Change
91.09 ^USD	-0.08%		+0.13%	-4.19%

Mar. 25	UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says	MT
Mar. 25	Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says	Mar. 25	MT
Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says	Mar. 25	MT
RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating	Mar. 25	MT
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys	Mar. 19	RE
UnitedHealth Faces Antitrust Probe in US	Feb. 28	MT
Amedisys: Q4 Earnings Snapshot	Feb. 21	AQ
Earnings Flash (AMED) AMEDISYS Reports Q4 EPS $0.94	Feb. 21	MT
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results	Feb. 21	AQ
Amedisys, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 21	CI
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis	Feb. 08	AQ
Amedisys, Inc. Offers Advanced Molecular Testing to its Care Centers in Collaboration with Patient Choice Laboratories	Feb. 08	CI
Amedisys Finds Answer Key in Medalogix Pulse	Dec. 29	AQ
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023.	23-10-25	CI
Amedisys Q3 Adjusted Earnings, Net Service Revenue Decline	23-10-25	MT
Amedisys: Q3 Earnings Snapshot	23-10-24	AQ
Earnings Flash (AMED) AMEDISYS Posts Q3 EPS $0.98	23-10-24	MT
Amedisys, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-24	CI
Amedisys Reports Third Quarter 2023 Financial Results	23-10-24	AQ
Amedisys Celebrates National Quality Week	23-10-18	AQ
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating	23-09-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Amedisys, Inc.

Equities

AMED

US0234361089

Summary

Filters